
Sotera Health (SHC) | Stock Overview & Key Data
Sotera Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $30.38 on March 15, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Sotera Health SHC | 4.60B Mid-cap | -0.37% | 34.84% | 32.23% | 31.28% | 20.19% | 6.02% | -3.25% | -34.78% |
Thermo Fisher TMO | 183.80B Large-cap | -1.45% | 2.19% | 22.04% | -6.85% | -5.71% | -19.89% | -9.35% | 20.18% |
Danaher DHR | 146.73B Large-cap | -2.82% | -0.50% | 8.06% | -0.93% | -10.44% | -23.58% | -13.83% | 18.10% |
Exact Sciences EXAS | 9.01B Mid-cap | -0.11% | -0.25% | -17.70% | 0.02% | -16.70% | -23.13% | 31.39% | -36.52% |
Charles River CRL | 8.01B Mid-cap | 0.91% | -8.48% | 18.60% | -1.21% | -10.58% | -17.42% | -18.44% | -20.20% |
Guardant Health GH | 7.90B Mid-cap | 9.80% | 55.63% | 74.89% | 58.45% | 112.21% | 163.57% | 26.94% | -25.76% |
Ownership & Short Interest
Sotera Health Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Sotera Health would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SHC's 52-week high and low?
- In the last 52 weeks, Sotera Health reached a high of $17.08 (on September 9, 2024) and a low of $9.53 (on April 9, 2025).
- What is the market cap and P/E ratio for SHC?
- Curious about Sotera Health's size and valuation? Its market capitalization stands at 4.60B. When it comes to valuation, the P/E ratio (trailing twelve months) is 180.00, and the forward P/E (looking ahead) is 20.00.
- Does SHC pay dividends? If so, what's the yield?
- As for dividends, Sotera Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Sotera Health's main competitors or similar companies to consider before investing?
When looking at Sotera Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO183.80B Healthcare Diagnostics & Research -19.89% -9.35% Danaher
DHR146.73B Healthcare Diagnostics & Research -23.58% -13.83% Exact Sciences
EXAS9.01B Healthcare Diagnostics & Research -23.13% 31.39% Charles River
CRL8.01B Healthcare Diagnostics & Research -17.42% -18.44% Guardant Health
GH7.90B Healthcare Diagnostics & Research 163.57% 26.94% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Sotera Health Company? (e.g., ROE, Debt/Equity)
- To get a sense of Sotera Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.14%, the Debt to Equity ratio from the most recent quarter is 460.02, and its Gross Profit Margin stands at 56.61%.
- What is the recent revenue and earnings growth for SHC?
- Looking at Sotera Health's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 6.40%, and quarterly earnings saw a YoY growth of -9.00%.
- How much of SHC stock is held by insiders and institutions?
- Wondering who owns Sotera Health stock? Company insiders (like executives and directors) hold about 2.46% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 96.47%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.